Document is current
Any future updates will be listed below
-
Authors
Charles, Cécile https://orcid.org/0000-0003-3126-1337
Di Meglio, Antonio
Arnedos, Monica
Arvis, Johanna
Baciarello, Giulia
Blanchard, Pierre
Djehal, Nardjes
Dumas, Agnès
Hollbecque, Antoine
Martin, Elise
Matias, Margarida
Menvielle, Gwenn
Zingarello, Anna
Dauchy, Sarah
Vaz-Luis, Ines
-
Funding
Funding for this research was provided by:
Susan G. Komen
Odyssea Fundation
Fondation Aide à la Recherche contre le Cancer
- License Information
-
More Information
Article History
Received: 2 October 2020
Accepted: 2 February 2021
First Online: 5 February 2021
Declarations
:
: The study protocol was approved by the French regulatory and ethics authorities’ (N° ID IRB 2017-A01944-49).All participants received oral and written information about the purpose and the procedures of the study, before signing a consent form.
: We confirm that the manuscript has been read and approved for submission by all authors; all persons listed as authors have contributed to the preparation of this manuscript and no persons other than the listed authors have contributed significantly to its preparation.
: A. Di Meglio reports personal fees from Thermo Fisher and grants from the European Society for Medical Oncology (ESMO; clinical research fellowship), outside the submitted work. I. Vaz-Luis reports personal fees from AstraZeneca, Kephren, Amgen, and Novartis, outside the submitted work. No other authors reported any disclosures.
